ITRM20080551A1 - Derivati anfifilici del poliossietilenglicole (peg), procedimento di preparazione e loro usi nella preparazione di sistemi farmaceutici. - Google Patents

Derivati anfifilici del poliossietilenglicole (peg), procedimento di preparazione e loro usi nella preparazione di sistemi farmaceutici.

Info

Publication number
ITRM20080551A1
ITRM20080551A1 IT000551A ITRM20080551A ITRM20080551A1 IT RM20080551 A1 ITRM20080551 A1 IT RM20080551A1 IT 000551 A IT000551 A IT 000551A IT RM20080551 A ITRM20080551 A IT RM20080551A IT RM20080551 A1 ITRM20080551 A1 IT RM20080551A1
Authority
IT
Italy
Prior art keywords
preparation
polyossiethylene
amphifyl
peg
glycol
Prior art date
Application number
IT000551A
Other languages
English (en)
Inventor
Alberto Ballistreri
Giuseppe Impallomeni
Valentina Panto'
Rosario Pignatello
Giovanni Puglisi
Original Assignee
Univ Catania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Catania filed Critical Univ Catania
Priority to IT000551A priority Critical patent/ITRM20080551A1/it
Publication of ITRM20080551A1 publication Critical patent/ITRM20080551A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33396—Polymers modified by chemical after-treatment with organic compounds containing nitrogen having oxygen in addition to nitrogen
IT000551A 2008-10-15 2008-10-15 Derivati anfifilici del poliossietilenglicole (peg), procedimento di preparazione e loro usi nella preparazione di sistemi farmaceutici. ITRM20080551A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT000551A ITRM20080551A1 (it) 2008-10-15 2008-10-15 Derivati anfifilici del poliossietilenglicole (peg), procedimento di preparazione e loro usi nella preparazione di sistemi farmaceutici.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000551A ITRM20080551A1 (it) 2008-10-15 2008-10-15 Derivati anfifilici del poliossietilenglicole (peg), procedimento di preparazione e loro usi nella preparazione di sistemi farmaceutici.

Publications (1)

Publication Number Publication Date
ITRM20080551A1 true ITRM20080551A1 (it) 2010-04-16

Family

ID=40933125

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000551A ITRM20080551A1 (it) 2008-10-15 2008-10-15 Derivati anfifilici del poliossietilenglicole (peg), procedimento di preparazione e loro usi nella preparazione di sistemi farmaceutici.

Country Status (1)

Country Link
IT (1) ITRM20080551A1 (it)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0401384A1 (en) * 1988-12-22 1990-12-12 Kirin-Amgen, Inc. Chemically modified granulocyte colony stimulating factor
WO1992016555A1 (en) * 1991-03-18 1992-10-01 Enzon, Inc. Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
EP0511903A2 (fr) * 1991-04-23 1992-11-04 Teva Pharmaceutical Industries Ltd. Conjugué de calcitonine et de polyéthylène glycol
WO2000040203A2 (en) * 1999-01-08 2000-07-13 Emisphere Technologies, Inc. Polymeric delivery agents and delivery agent compounds
WO2002076506A1 (fr) * 2001-03-28 2002-10-03 Physica S.A.R.L. Utilisation de lipoaminoacides comme promoteurs d'absorption dans une composition pharmaceutique
EP1489125A1 (en) * 2002-03-05 2004-12-22 Beijing Jiankai Technology Co., Ltd. Compound of hydrophilic polymer-polycarboxyl oligopeptide and medicines, medical composite comprising above compound and use of above compound in medicimes
WO2005121181A1 (fr) * 2004-06-11 2005-12-22 Beijing Jenkem Technology Co., Ltd. Polyethyleneglycol-oligopeptides de type branchement d'arbre multipoint et leurs derives actifs et composes

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0401384A1 (en) * 1988-12-22 1990-12-12 Kirin-Amgen, Inc. Chemically modified granulocyte colony stimulating factor
WO1992016555A1 (en) * 1991-03-18 1992-10-01 Enzon, Inc. Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
EP0511903A2 (fr) * 1991-04-23 1992-11-04 Teva Pharmaceutical Industries Ltd. Conjugué de calcitonine et de polyéthylène glycol
WO2000040203A2 (en) * 1999-01-08 2000-07-13 Emisphere Technologies, Inc. Polymeric delivery agents and delivery agent compounds
WO2002076506A1 (fr) * 2001-03-28 2002-10-03 Physica S.A.R.L. Utilisation de lipoaminoacides comme promoteurs d'absorption dans une composition pharmaceutique
EP1489125A1 (en) * 2002-03-05 2004-12-22 Beijing Jiankai Technology Co., Ltd. Compound of hydrophilic polymer-polycarboxyl oligopeptide and medicines, medical composite comprising above compound and use of above compound in medicimes
WO2005121181A1 (fr) * 2004-06-11 2005-12-22 Beijing Jenkem Technology Co., Ltd. Polyethyleneglycol-oligopeptides de type branchement d'arbre multipoint et leurs derives actifs et composes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200608, Derwent World Patents Index; AN 2006-078772, XP002541797 *

Similar Documents

Publication Publication Date Title
SMT201600225B (it) DERIVATI DI 1,2,4-TIAZOLlDIN-3-0NE E LORO USO NEL TRATTAMENTO DEL CANCRO
CL2014002358A1 (es) Formas polimorficas de (s)-2-(1-(9h-purin-6-ilamino)propil)-5-fluoro-3-fenilquinazolin-4(3h)-ona; metodos de preparacion; composiciones farmaceuticas que las comprenden y uso en el tratamiento del cancer.
BRPI1008045A2 (pt) derivados de aminotetralina, composições farmacêuticas contendo-os, e seu uso em terapia
CL2014003171A1 (es) Composicion liofilizada que comprende al menos una benzodiazepina de formula (i), al menos un excipiente higroscopico seleccionado de disacaridos y dextrano; metodo de preparacion de la composicion farmaceutica.
WO2013173789A3 (en) Antisense oligonucleotide compositions
PT2655375E (pt) Derivados de pirimidinona, sua preparação e sua utilização farmacêutica
IL223463A (en) Urea History, Pharmaceutical Preparations Containing and Uses
BR112012003842A2 (pt) composição farmacêutica, método de formulação e uso da mesma
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
EP3334719A4 (en) SUBSTITUTED BENZIMIDAZOLES, PREPARATION AND USE THEREOF AS PHARMACEUTICAL AGENTS
EP2978423A4 (en) STABLE NANO COMPOSITION WITH DOXORUBICIN, PROCESS FOR THE PREPARATION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH
BRPI0915527A2 (pt) pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
IT1391734B1 (it) Nuovi biomateriali, loro preparazione per elettrospinning e loro uso in campo biomedico e chirurgico.
HK1256674A1 (zh) 氘修飾的brigatinib衍生物、含有該化合物的藥物組合物及其用途
BR112016027043A2 (pt) Combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
GB201513741D0 (en) Positioning, quick-release bioadhesion agent and use
EP2261221A4 (en) EPOTHILONE ANALOGUES, THEIR PHARMACEUTICAL COMPOSITIONS, THEIR USE AND PREPARATIONS
AU2016289474B2 (en) HBED-bisphosphonates, radiometal conjugates thereof and their use as theranostic agents
EP3339305A4 (en) INDOLE DERIVATIVE PRODUCTION METHOD AND USE THEREOF IN PHARMACEUTICAL MEDICAMENTS
FR2976799B1 (fr) Composition cosmetique comprenant au moins un polymere amphotere particulier et un agent antipelliculaire.
EP3534961A4 (en) STABLE AQUEOUS INJECTABLE CAPSAICIN FORMULATIONS AND MEDICAL USES THEREOF
BRPI1009067A2 (pt) derivados de nitrila, seu uso farmaceutico e composições
BR112014025416A2 (pt) AGENTES ANTIMALÁRICOS, COMPOSIÇÃO FARMACEUTICA COMPREENDENDO-OS E USO Dos MESMOS.
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas